Navigation Links
Applied BioMath, LLC presents work in immuno-oncology and antibody drug-conjugates at Keystone Symposium
Date:1/24/2017

LINCOLN, Mass., Jan. 24, 2017 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in a Keystone Symposium on Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies.  Anna Katharina Wilkins, PhD, Senior Scientist at Applied BioMath will present a poster titled "Computational exploration of mechanistic determinants of antibody drug-conjugate pharmacokinetics using quantitative systems pharmacology modeling strategies."  In addition, Jennifer Park, PhD, Director of Business Development at Applied BioMath will present a poster titled "Quantitative systems pharmacology and immunotherapy:  accelerating lead generation and optimization of a PD-1 x TIM-3 biotherapeutic in immuno-oncology."

"Applied BioMath is committed to pushing the envelope in the field of quantitative systems pharmacology as well as educating scientists about the value of incorporating such technology into their drug research and development," said Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath.  "This Keystone Symposium provides an ideal environment for us to present our cutting-edge research to scientists from leading industry and academic institutions as well as regulatory agencies."        

About Applied BioMath

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, helps biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in R&D.   Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and decades of industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward.   Our involvement shortens project timelines, lowers cost, and increases the likelihood of a best-in-class drug.  We provide clarity to complex situations, answer otherwise unanswerable questions, and our approach, when validated in the clinic, is 10x more accurate than traditional methodologies.

Applied BioMath and the Applied BioMath logo are trademarks of Applied BioMath, LLC.

Press contact:
Kristen Zannella
kristen.zannella@appliedbiomath.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/applied-biomath-llc-presents-work-in-immuno-oncology-and-antibody-drug-conjugates-at-keystone-symposium-300396010.html


'/>"/>
SOURCE Applied BioMath
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
2. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
3. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
4. Best papers in applied technology from Springer journals chosen
5. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
6. Dr. Rongxiang Xu: Mankind Is Entering New Era of Applied Organ Regeneration Science
7. Pittcon Recognizes Outstanding Achievements in Analytical Chemistry and Applied Spectroscopy
8. Applied Silicone Launches Ultra-Soft LSR
9. CAP Technology is Being Applied to Isolation/Containment Applications Worldwide
10. Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences
11. Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Charlotte, N.C. (PRWEB) , ... October 09, 2017 , ... ... Purple announced Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and ... Dr. Stubbs was a member of the winning team for the 2015 Breakthrough Prize ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
Breaking Biology News(10 mins):